Literature DB >> 12114816

Endocrine Cell Replacement of Oxyntic Glands in Zollinger-Ellison Syndrome: A Role for Female Sex Hormones?

Cesare Bordi1, Cinzia Azzoni, Tiziana D'Adda, Anna Bertele, Riccardo Volpi, Angelo Franze.   

Abstract

A 48-year-old woman with Zollinger-Ellison syndrome (ZES), but no evidence of multiple endocrine neoplasia (MEN)-1 syndrome, developed an unusually florid evolution of enterochromaffin-like (ECL) cell hyperplasia, which led to extensive replacement of oxyntic glands by endocrine tissue and resulted in the disappearance of the patient's gastric acid hypersecretion with antisecretory treatment no longer required. The patient's previous history included breast cancer, treated with surgery and 5 years of antiestrogen therapy, and bilateral granulosathecal cell tumor of the ovary. In addition, increased circulating levels of 17 B-estradiol (17BE) and progesterone, possibly depending on concomitant development of liver cirrhosis, were also found. On the basis of these associations, it is suggested that abnormalities in the domain of female sex hormones, with a potential synergistic role of liver dysfunction, may be involved in the florid evolution of hypergastrinemia-driven proliferation of ECL cells observed in the present case.

Entities:  

Year:  1995        PMID: 12114816     DOI: 10.1007/bf02738734

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  22 in total

1.  Letter: ECL cell proliferation and gastrin levels.

Authors:  C Bordi; A Costa; G Missale
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

2.  Clinical recovery owing to target parietal cell failure in a patient with Zollinger-Ellison syndrome.

Authors:  W M Wiersinga; G N Tytgat
Journal:  Gastroenterology       Date:  1977-12       Impact factor: 22.682

3.  Serum gastrin concentration affects the self replication rate of the enterochromaffin like cells in the rat stomach.

Authors:  Y Tielemans; J Axelson; F Sundler; G Willems; R Håkanson
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

4.  The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.

Authors:  P N Maton; E E Lack; M J Collen; M J Cornelius; E David; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

5.  Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions, and carcinoids arising in chronic atrophic gastritis.

Authors:  E Solcia; R Fiocca; L Villani; A Gianatti; M Cornaggia; A Chiaravalli; M Curzio; C Capella
Journal:  Scand J Gastroenterol Suppl       Date:  1991

6.  Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases.

Authors:  C Bordi; J Y Yu; M T Baggi; C Davoli; F P Pilato; G Baruzzi; G Gardini; G Zamboni; G Franzin; M Papotti
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

7.  Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.

Authors:  T Lehy; G Cadiot; M Mignon; P Ruszniewski; S Bonfils
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

8.  Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment.

Authors:  T Lehy; M Mignon; G Cadiot; L Elouaer-Blanc; P Ruszniewski; M J Lewin; S Bonfils
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

Review 9.  Hypergastrinemia and gastric enterochromaffin-like cells.

Authors:  C Bordi; T D'Adda; C Azzoni; F P Pilato; P Caruana
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

10.  Spontaneous achlorhydria with atrophic gastritis in the Zollinger-Ellison syndrome.

Authors:  H G Desai; F P Antia
Journal:  Gut       Date:  1969-11       Impact factor: 23.059

View more
  2 in total

Review 1.  Pathogenesis of ECL cell tumors in humans.

Authors:  C Bordi; T D'Adda; C Azzoni; G Ferraro
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 2.  Hypergastrinemia.

Authors:  Sunil Dacha; Mohammed Razvi; Julia Massaad; Qiang Cai; Mohammad Wehbi
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.